BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36008770)

  • 21. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
    Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
    Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience.
    Duran E; Yıldırım T; Taghiyeva A; Bilgin E; Arıcı M; Sağlam EA; Özen S; Üner M; Erdem Y; Kalyoncu U; Ertenli AI
    Lupus; 2022 Aug; 31(9):1147-1156. PubMed ID: 35658643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
    Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
    Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    Hailu GT; Hussen SU; Getachew S; Berha AB
    BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is podocytopathy another image of renal affection in p-SLE?
    Abdelnabi HH
    Pediatr Rheumatol Online J; 2021 Apr; 19(1):57. PubMed ID: 33902643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience.
    Ahn SS; Yoo J; Lee SW; Song JJ; Park YB; Jung SM
    Lupus; 2022 Apr; 31(5):588-595. PubMed ID: 35316102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
    Nezhad ST; Sepaskhah R
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China.
    Song K; Liu X; Liu J; Yin Z; Chen P; Cai G; Chen X
    Clin Rheumatol; 2020 Nov; 39(11):3353-3363. PubMed ID: 32435895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors of childhood systemic lupus erythematosus with thyroid dysfunction].
    Zhang YY; Huang LM; Cao L; Zhi YZ; Zhang JJ
    Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):250-255. PubMed ID: 36849353
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
    Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
    Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
    Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of lupus and lupus nephritis at a tertiary care center in Lebanon.
    Koubar SH; Kort J; Kawtharani S; Chaaya M; Makki M; Uthman I
    Lupus; 2019 Nov; 28(13):1598-1603. PubMed ID: 31554458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis.
    Hachiya A; Karasawa M; Imaizumi T; Kato N; Katsuno T; Ishimoto T; Kosugi T; Tsuboi N; Maruyama S
    Sci Rep; 2021 Jan; 11(1):1525. PubMed ID: 33452282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China.
    Tao J; Wang H; Yu XJ; Tan Y; Yu F; Wang SX; Haas M; Glassock RJ; Zhao MH
    Am J Nephrol; 2020; 51(6):483-492. PubMed ID: 32320985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
    Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.